Physician Wealth Advisors Inc. Acquires Shares of 1,663 Oracle Co. (NYSE:ORCL)

Physician Wealth Advisors Inc. bought a new position in shares of Oracle Co. (NYSE:ORCL) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 1,663 shares of the enterprise software provider’s stock, valued at approximately $201,000.

A number of other institutional investors also recently modified their holdings of ORCL. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Oracle by 39.8% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 7,991 shares of the enterprise software provider’s stock worth $846,000 after purchasing an additional 2,276 shares during the period. Rehmann Capital Advisory Group raised its position in Oracle by 5.6% in the 3rd quarter. Rehmann Capital Advisory Group now owns 10,040 shares of the enterprise software provider’s stock valued at $1,064,000 after buying an additional 534 shares during the last quarter. Jones Financial Companies Lllp raised its position in Oracle by 27.5% in the 3rd quarter. Jones Financial Companies Lllp now owns 49,785 shares of the enterprise software provider’s stock valued at $5,273,000 after buying an additional 10,748 shares during the last quarter. Gallagher Fiduciary Advisors LLC raised its position in Oracle by 23.8% in the 3rd quarter. Gallagher Fiduciary Advisors LLC now owns 3,042 shares of the enterprise software provider’s stock valued at $322,000 after buying an additional 585 shares during the last quarter. Finally, Insigneo Advisory Services LLC raised its position in Oracle by 28.8% in the 3rd quarter. Insigneo Advisory Services LLC now owns 7,942 shares of the enterprise software provider’s stock valued at $841,000 after buying an additional 1,777 shares during the last quarter. 42.44% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ORCL. The Goldman Sachs Group increased their price target on Oracle from $115.00 to $130.00 and gave the company a “neutral” rating in a research report on Wednesday, March 13th. William Blair raised Oracle from a “market perform” rating to an “outperform” rating in a research report on Tuesday, March 12th. Stifel Nicolaus upped their price objective on Oracle from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Wednesday, June 12th. Mizuho upped their price objective on Oracle from $160.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, June 17th. Finally, TD Cowen upped their price objective on Oracle from $145.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, June 12th. Fourteen equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat, Oracle has an average rating of “Moderate Buy” and an average price target of $145.83.

Insider Activity at Oracle

In other Oracle news, Director George H. Conrades sold 20,000 shares of Oracle stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $116.00, for a total value of $2,320,000.00. Following the transaction, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,068,976. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Oracle news, Director George H. Conrades sold 20,000 shares of Oracle stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $116.00, for a total value of $2,320,000.00. Following the transaction, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,068,976. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Edward Screven sold 235,918 shares of Oracle stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total value of $34,042,967.40. Following the completion of the transaction, the insider now directly owns 2,626,764 shares in the company, valued at $379,042,045.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 385,639 shares of company stock valued at $53,002,729. Corporate insiders own 42.80% of the company’s stock.

Oracle Price Performance

NYSE ORCL traded up $1.02 during trading hours on Friday, hitting $141.20. The company had a trading volume of 25,814,821 shares, compared to its average volume of 11,264,646. Oracle Co. has a 52 week low of $99.26 and a 52 week high of $145.32. The firm has a 50 day simple moving average of $125.24 and a 200 day simple moving average of $118.08. The company has a debt-to-equity ratio of 8.25, a quick ratio of 0.72 and a current ratio of 0.71. The firm has a market capitalization of $389.13 billion, a price-to-earnings ratio of 38.06, a PEG ratio of 2.54 and a beta of 1.01.

Oracle (NYSE:ORCL) last released its quarterly earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 earnings per share for the quarter, missing the consensus estimate of $1.65 by ($0.02). Oracle had a net margin of 19.76% and a return on equity of 223.01%. The business had revenue of $14.29 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same period in the previous year, the business earned $1.35 EPS. The business’s revenue was up 3.3% on a year-over-year basis. Equities research analysts expect that Oracle Co. will post 5.01 earnings per share for the current year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Shareholders of record on Thursday, July 11th will be issued a $0.40 dividend. The ex-dividend date is Thursday, July 11th. This represents a $1.60 annualized dividend and a dividend yield of 1.13%. Oracle’s payout ratio is currently 43.13%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.